(Q34573702)

3 August 2017

title

Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients (English)

1 reference

3 August 2017

main subject

gram-positive bacteria

0 references

1 reference

1 reference

1 reference

Yu-Chung Chuang

5

0 references

Aristine Cheng

Aristine Cheng

4

0 references

Wang-Huei Sheng

Wang-Huei Sheng

2

0 references

Jann-Tay Wang

Jann-Tay Wang

3

0 references

Yee-Chun Chen

Yee-Chun Chen

6

0 references

Chang Shan-chwen

Shan-Chwen Chang

7

0 references

Chung-Chih Lai

1

Chung-Chih Lai

1 reference

3 August 2017

publication date

4 February 2013

1 reference

3 August 2017

published in

BMC Infectious Diseases

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

page(s)

66

1 reference

Daptomycin: evaluation of a high-dose treatment strategy

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

High-dose daptomycin in documented Staphylococcus aureus infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

The pharmacokinetic and pharmacodynamic properties of vancomycin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

Development of daptomycin for gram-positive infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571896

International study of the prevalence and outcomes of infection in intensive care units

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

Pharmacokinetics and safety of multiple intravenous doses of daptomycin in a Taiwanese adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-66

High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23379510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23379510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-13-66

1 reference

3 August 2017

1 reference

3 August 2017

1 reference